Holen Sie sich die Stockscreener-App
133.51
0.87%
-1.17
Handel nachbörslich:
133.00
-0.51
-0.38%
Schlusskurs vom Vortag:
$134.68
Offen:
$133.55
24-Stunden-Volumen:
514.97K
Relative Volume:
0.96
Marktkapitalisierung:
$6.66B
Einnahmen:
$338.46M
Nettoeinkommen (Verlust:
$-310.96M
KGV:
-20.45
EPS:
-6.53
Netto-Cashflow:
$-132.82M
1W Leistung:
+1.61%
1M Leistung:
+14.35%
6M Leistung:
+24.50%
1J Leistung:
+48.16%
1-Tages-Spanne:
$132.61
$136.23
1-Wochen-Bereich:
$126.80
$136.23
52-Wochen-Spanne:
$75.56
$139.13
Axsome Therapeutics Inc Stock (AXSM) Company Profile
Firmenname
Axsome Therapeutics Inc
Sektor
Branche
Telefon
(212) 332-3241
Adresse
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Vergleichen Sie AXSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
133.51 | 6.72B | 338.46M | -310.96M | -132.82M | -6.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.39 | 107.73B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.48 | 62.04B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
475.91 | 62.73B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
836.39 | 51.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.29 | 34.67B | 398.11M | -1.03B | -868.57M | -5.7032 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | B. Riley Securities | Buy |
| 2025-09-03 | Fortgesetzt | Wells Fargo | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-03 | Eingeleitet | Oppenheimer | Outperform |
| 2025-04-07 | Eingeleitet | Jefferies | Buy |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-12-31 | Bestätigt | Mizuho | Outperform |
| 2024-09-03 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-06 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-07-22 | Eingeleitet | Needham | Buy |
| 2024-04-29 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-06 | Eingeleitet | UBS | Buy |
| 2024-01-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-12-13 | Eingeleitet | Citigroup | Buy |
| 2023-08-08 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-01-05 | Eingeleitet | Piper Sandler | Neutral |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2022-09-07 | Fortgesetzt | Mizuho | Buy |
| 2021-08-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | Eingeleitet | Berenberg | Buy |
| 2021-01-08 | Eingeleitet | Jefferies | Buy |
| 2020-12-16 | Eingeleitet | Mizuho | Buy |
| 2020-09-29 | Eingeleitet | BofA Securities | Underperform |
| 2020-09-10 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-04-28 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-14 | Eingeleitet | Cowen | Outperform |
| 2019-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-17 | Bestätigt | H.C. Wainwright | Buy |
| 2019-12-16 | Bestätigt | Guggenheim | Buy |
| 2019-10-16 | Eingeleitet | Guggenheim | Buy |
| 2019-09-18 | Eingeleitet | William Blair | Outperform |
| 2019-05-28 | Eingeleitet | SunTrust | Buy |
| 2019-05-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-04-08 | Eingeleitet | SVB Leerink | Outperform |
| 2019-03-15 | Bestätigt | H.C. Wainwright | Buy |
| 2016-10-03 | Fortgesetzt | Brean Capital | Buy |
| 2015-12-15 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-12-14 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Axsome Therapeutics Inc Aktie (AXSM) Neueste Nachrichten
How rising interest rates impact Axsome Therapeutics Inc. stockEarnings Miss & Technical Entry and Exit Alerts - newser.com
Historical volatility pattern of Axsome Therapeutics Inc. visualized2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com
Can machine learning forecast Axsome Therapeutics Inc. recoveryEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
Market reaction to Axsome Therapeutics Inc.’s recent news2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Peregrine Capital Management LLC Acquires 13,747 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc. stock trend forecastInsider Selling & Stock Portfolio Risk Management - newser.com
How Axsome Therapeutics Inc. stock performs in rate cut cyclesWeekly Investment Summary & Expert Approved Trade Ideas - newser.com
Has Axsome Therapeutics Inc. formed a bullish divergenceMarket Sentiment Report & Short-Term High Return Strategies - newser.com
Can Axsome Therapeutics Inc. stock continue upward trendJuly 2025 Setups & Technical Pattern Based Buy Signals - newser.com
Allianz Asset Management GmbH Increases Holdings in Axsome Therapeutics, Inc. $AXSM - MarketBeat
Axsome Therapeutics Inc. stock volume spike explainedJuly 2025 Decliners & Fast Exit Strategy with Risk Control - newser.com
How Axsome Therapeutics Inc. stock compares to market leaders2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
Is Axsome Therapeutics Inc. stock attractive after correctionWeekly Market Outlook & Weekly High Return Stock Opportunities - newser.com
Is Axsome Therapeutics Inc. stock a buy on dipsJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
How supply chain issues affect Axsome Therapeutics Inc. stock2025 Winners & Losers & Weekly Stock Performance Updates - Fundação Cultural do Pará
How Axsome Therapeutics Inc. (19X) stock reacts to Fed tightening2025 Top Gainers & Smart Allocation Stock Tips - newser.com
Bull Bear: Is Axsome Therapeutics Inc. stock a top pick in earnings seasonQuarterly Growth Report & Fast Moving Trade Plans - Fundação Cultural do Pará
Tools to assess Axsome Therapeutics Inc.’s risk profile2025 Winners & Losers & Risk Managed Investment Strategies - newser.com
Is a relief rally coming for Axsome Therapeutics Inc. holdersCPI Data & Low Volatility Stock Recommendations - newser.com
Is Axsome Therapeutics Inc. stock gaining market sharePortfolio Risk Summary & Reliable Price Action Trade Plans - newser.com
What Wall Street predicts for Axsome Therapeutics Inc. stock priceTrade Performance Summary & Low Volatility Stock Suggestions - newser.com
Axsome Therapeutics Advances Study on Solriamfetol for Binge Eating Disorder - TipRanks
Axsome Therapeutics’ AXS-05 Study: A Potential Game-Changer for MDD Relapse Prevention - TipRanks
Axsome Therapeutics (AXSM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - sharewise.com
What candlestick patterns are forming on Axsome Therapeutics Inc.Earnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Is Axsome Therapeutics Inc. forming a reversal patternGold Moves & Low Risk High Reward Ideas - newser.com
Axsome Therapeutics (AXSM) Projected to Post Earnings on Monday - MarketBeat
Surprises Report: How rising interest rates impact Axsome Therapeutics Inc. stockJuly 2025 Recap & Fast Moving Market Watchlists - Fundação Cultural do Pará
Published on: 2025-10-27 05:40:44 - newser.com
2,100 Shares in Axsome Therapeutics, Inc. $AXSM Bought by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Finanzdaten der Axsome Therapeutics Inc-Aktie (AXSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.28%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):